Core Viewpoint - Wolters Kluwer has repurchased 238,453 ordinary shares for €21.4 million at an average price of €89.85 during the period from December 11 to December 17, 2025, as part of its ongoing share buyback program [1][2]. Share Buyback Program - The share buyback program was announced on November 5, 2025, with a total repurchase target of up to €200 million from November 6, 2025, to February 23, 2026 [2]. - As of the current date in 2025, a cumulative total of 8,299,353 shares have been repurchased for a total consideration of €1,076.3 million, with an average share price of €129.69 [2]. Treasury Shares - Shares repurchased will be held as treasury shares and are intended for capital reduction through share cancellation [3]. Company Overview - Wolters Kluwer is a global leader in professional information solutions, software, and services, serving customers in various sectors including healthcare, tax, accounting, and legal [4]. - The company reported annual revenues of €5.9 billion for 2024 and operates in over 40 countries with approximately 21,900 employees [5].

Group 1 - Wolters Kluwer's CCH Tagetik Intelligent Platform has received the IBM Cloud for Financial Services Validated designation [1] - The IBM Cloud for Financial Services framework aims to help institutions mitigate risk and accelerate innovation [1] - The designation ensures that solutions comply with stringent regulatory and security standards [1]

Core Insights - Nursing students encounter various challenges, including the application of theoretical knowledge and mastering complex terminology [1] - Wolters Kluwer Health has launched Lippincott® CoursePoint+ with Expert AI to assist nursing students in enhancing their understanding of concepts and curriculum [1] Company Overview - Wolters Kluwer Health is focused on improving educational outcomes for nursing students through innovative learning solutions [1] - The introduction of Lippincott® CoursePoint+ is based on extensive input and testing from nursing educators [1]

Core Insights - The healthcare sector is expected to see significant gains in AI adoption as 2026 approaches, with a focus on strategic implementation of productivity enablers and advancements in clinical decision-making technology [1] Group 1: AI Adoption in Healthcare - Predictions indicate that the healthcare industry will increasingly adopt AI technologies to enhance productivity and improve patient care [1] - Experts from Wolters Kluwer Health are highlighting the obstacles and opportunities that lie ahead in healthcare technology as the industry moves towards 2026 [1]

Core Insights - Wolters Kluwer has repurchased 209,603 ordinary shares for €18.7 million at an average price of €89.33 during the period from December 4 to December 10, 2025 [1] - The share buyback program, announced on November 5, 2025, aims to repurchase shares up to €200 million from November 6, 2025, to February 23, 2026 [2] - Cumulatively, 8,060,900 shares have been repurchased in 2025, totaling €1,054.9 million at an average price of €130.86 [2] Share Buyback Program Details - The company has engaged a third party to execute the €200 million buyback program within legal limits [2] - Shares repurchased will be held as treasury shares and used for capital reduction through share cancellation [3] Company Overview - Wolters Kluwer is a global leader in professional information solutions, software, and services across various sectors including healthcare, tax, accounting, and legal [4] - The company reported annual revenues of €5.9 billion in 2024 and operates in over 180 countries with approximately 21,900 employees [5] - Wolters Kluwer shares are listed on Euronext Amsterdam and included in major indices such as AEX and Euro Stoxx 50 [6]

Core Viewpoint - Wolters Kluwer has initiated a share buyback program, repurchasing a total of 209,603 shares for €18.7 million at an average price of €89.33 during the specified period, as part of a larger plan to repurchase shares worth up to €200 million by February 23, 2026 [1][2]. Share Buyback Program - The share buyback program was announced on November 5, 2025, with a total intended repurchase of €200 million from November 6, 2025, to February 23, 2026 [2]. - Cumulatively, 8,060,900 shares have been repurchased in 2025, totaling €1,054.9 million, with an average share price of €130.86 [2]. Treasury Shares and Capital Reduction - Shares repurchased will be held as treasury shares and are intended for capital reduction through share cancellation [3]. Company Overview - Wolters Kluwer reported annual revenues of €5.9 billion for 2024, serving customers in over 180 countries and employing approximately 21,900 people globally [4]. - The company is headquartered in Alphen aan den Rijn, Netherlands, and is listed on Euronext Amsterdam [5].

Core Insights - Wolters Kluwer Health and ABMS have announced a collaboration aimed at streamlining healthcare improvement initiatives [1] Group 1 - The partnership is expected to enhance the efficiency of healthcare services and improve patient outcomes [1] - This collaboration will leverage data and technology to support healthcare providers in their improvement efforts [1] - The initiative aligns with the growing trend of integrating technology in healthcare to drive better results [1]

Wolters Kluwer Investor Call Summary Company Overview - **Company**: Wolters Kluwer (OTCPK: WOLT.F) - **Industry**: Information Services, focusing on AI-driven solutions for tax, accounting, and healthcare sectors Key Points and Arguments AI Focus and Strategy - AI has been the primary topic of discussion among investors and analysts in recent months, highlighting its importance in Wolters Kluwer's strategy [2][3] - The company has transformed from a print-centric model to a digital expert solution provider, with nearly 70% of digital revenues now coming from AI-enabled products, up from 50% two years ago [6][9] - Significant investment of €650 million in product development, primarily focused on AI, is expected to drive growth and enhance customer value [8][9] Product Innovations - **CCH Access Cloud Platform**: A flagship product in the tax and accounting sector, generating $1.6 billion in revenue, with 60% from North America. It serves 10,000 firms, including 95 of the top 100 [21][22] - **UpToDate**: The largest product in the health division, trusted by over 3 million clinicians, with a net promoter score above 70 and retention rates above 90% [33][34] - Introduction of new AI-powered modules in CCH Access, aimed at streamlining tax workflows and enhancing client collaboration [24][25] AI Integration and Workflow Transformation - The company is leveraging agentic AI to automate complex workflows, moving towards a "no-touch" tax return process, which significantly reduces manual tasks for professionals [25][27] - UpToDate Expert AI is designed to provide fast, accurate clinical decision support, integrating seamlessly into healthcare workflows [36][41] - The AI Center of Excellence focuses on using generative AI to transform products and services, ensuring safety and trust through expert oversight [12][41] Competitive Advantages - Wolters Kluwer's deep domain expertise and proprietary content provide a competitive edge in developing AI solutions that are tailored to specific professional needs [17][18] - The integration of expert AI with trusted content helps prevent inaccuracies and enhances decision-making in high-stakes environments [41][42] - The company emphasizes transparency and user feedback in its AI solutions, ensuring continuous improvement and trust among users [52][54] Financial Performance and Growth Outlook - The company anticipates continued growth driven by AI innovations and strategic partnerships, with a focus on enhancing go-to-market capabilities [55][58] - Pricing models for AI solutions are evolving, with indications of a willingness to pay more for specific AI features that deliver tangible productivity gains [56][57] Future Directions - Wolters Kluwer aims to accelerate innovation through its Fab AI enablement platform, enhancing development cycles and expanding its AI capabilities [58] - The company is committed to embedding its solutions within customer workflows and ecosystems, driving productivity and better outcomes [55][56] Additional Important Insights - The call highlighted the importance of understanding customer workflows to effectively implement AI solutions, which can streamline processes and improve efficiency [15][16] - The company is actively monitoring competitive threats and adapting its strategies to maintain its leadership position in the market [60][63] This summary encapsulates the key insights from the Wolters Kluwer investor call, focusing on the company's strategic direction, product innovations, and competitive advantages in the AI landscape.

Wolters Kluwer Investor Teach-In: Artificial Intelligence December 8, 2025 Investor Teach-In: Artificial Intelligence – December 2025 1 Forward-looking statements This presentation contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from ...

Core Insights - Wolters Kluwer Health has launched a new Advanced Compounding module for Simplifi 797, designed to help pharmacies comply with the 2023 USP Chapter 797 requirements [1] Group 1 - The new module provides a comprehensive solution for complex compounding needs, including high-risk sterile processes and advanced batch tracking [1] - The system is designed as a closed-loop solution, enhancing efficiency and compliance in pharmacy operations [1] - Enhanced documentation and educational resources are included to support industry best practices as outlined by USP Chapter 797 [1]